nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP1A2—Gemfibrozil—coronary artery disease	0.0613	0.0957	CbGbCtD
Chlorzoxazone—CYP1A2—Clopidogrel—coronary artery disease	0.0531	0.083	CbGbCtD
Chlorzoxazone—CYP3A4—Ticagrelor—coronary artery disease	0.0451	0.0704	CbGbCtD
Chlorzoxazone—CYP3A4—Fenofibrate—coronary artery disease	0.0402	0.0627	CbGbCtD
Chlorzoxazone—CYP2D6—Niacin—coronary artery disease	0.0332	0.0518	CbGbCtD
Chlorzoxazone—CYP3A4—Gemfibrozil—coronary artery disease	0.0321	0.0501	CbGbCtD
Chlorzoxazone—CYP2D6—Timolol—coronary artery disease	0.0308	0.0482	CbGbCtD
Chlorzoxazone—CYP3A4—Clopidogrel—coronary artery disease	0.0278	0.0435	CbGbCtD
Chlorzoxazone—CYP2D6—Captopril—coronary artery disease	0.0272	0.0424	CbGbCtD
Chlorzoxazone—CYP2D6—Simvastatin—coronary artery disease	0.0262	0.041	CbGbCtD
Chlorzoxazone—CYP1A2—Losartan—coronary artery disease	0.0259	0.0405	CbGbCtD
Chlorzoxazone—CYP3A4—Eplerenone—coronary artery disease	0.0259	0.0404	CbGbCtD
Chlorzoxazone—CYP2D6—Pravastatin—coronary artery disease	0.0257	0.0401	CbGbCtD
Chlorzoxazone—CYP2D6—Lovastatin—coronary artery disease	0.0257	0.0401	CbGbCtD
Chlorzoxazone—CYP2D6—Atorvastatin—coronary artery disease	0.0234	0.0365	CbGbCtD
Chlorzoxazone—CYP3A4—Enalapril—coronary artery disease	0.0231	0.036	CbGbCtD
Chlorzoxazone—CYP3A4—Ezetimibe—coronary artery disease	0.0179	0.028	CbGbCtD
Chlorzoxazone—CYP3A4—Rosuvastatin—coronary artery disease	0.0179	0.028	CbGbCtD
Chlorzoxazone—CYP3A4—Simvastatin—coronary artery disease	0.0167	0.026	CbGbCtD
Chlorzoxazone—CYP3A4—Pravastatin—coronary artery disease	0.0163	0.0255	CbGbCtD
Chlorzoxazone—CYP3A4—Lovastatin—coronary artery disease	0.0163	0.0255	CbGbCtD
Chlorzoxazone—CYP3A4—Atorvastatin—coronary artery disease	0.0149	0.0232	CbGbCtD
Chlorzoxazone—CYP3A4—Losartan—coronary artery disease	0.0136	0.0212	CbGbCtD
Chlorzoxazone—KCNMA1—pulmonary artery—coronary artery disease	0.00533	0.481	CbGeAlD
Chlorzoxazone—KCNMA1—artery—coronary artery disease	0.00198	0.178	CbGeAlD
Chlorzoxazone—Ecchymosis—Losartan—coronary artery disease	0.00142	0.00752	CcSEcCtD
Chlorzoxazone—Drowsiness—Acetylsalicylic acid—coronary artery disease	0.00141	0.00746	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Niacin—coronary artery disease	0.00137	0.00726	CcSEcCtD
Chlorzoxazone—Dyspepsia—Pitavastatin—coronary artery disease	0.00131	0.00692	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Pitavastatin—coronary artery disease	0.00123	0.00648	CcSEcCtD
Chlorzoxazone—Lightheadedness—Ramipril—coronary artery disease	0.00121	0.00638	CcSEcCtD
Chlorzoxazone—Angioedema—Gemfibrozil—coronary artery disease	0.00118	0.00624	CcSEcCtD
Chlorzoxazone—Angioedema—Ticagrelor—coronary artery disease	0.00115	0.00609	CcSEcCtD
Chlorzoxazone—Dizziness—Tirofiban—coronary artery disease	0.00115	0.00609	CcSEcCtD
Chlorzoxazone—Lightheadedness—Lisinopril—coronary artery disease	0.00109	0.00579	CcSEcCtD
Chlorzoxazone—Dyspepsia—Penbutolol—coronary artery disease	0.00109	0.00575	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Gemfibrozil—coronary artery disease	0.00105	0.00557	CcSEcCtD
Chlorzoxazone—Angioedema—Rosuvastatin—coronary artery disease	0.00104	0.00549	CcSEcCtD
Chlorzoxazone—Drowsiness—Trandolapril—coronary artery disease	0.00101	0.00535	CcSEcCtD
Chlorzoxazone—Angioedema—Acetylsalicylic acid—coronary artery disease	0.00101	0.00533	CcSEcCtD
Chlorzoxazone—Dizziness—Pitavastatin—coronary artery disease	0.000983	0.0052	CcSEcCtD
Chlorzoxazone—Rash—Pitavastatin—coronary artery disease	0.000937	0.00496	CcSEcCtD
Chlorzoxazone—Drowsiness—Perindopril—coronary artery disease	0.000937	0.00496	CcSEcCtD
Chlorzoxazone—Dermatitis—Pitavastatin—coronary artery disease	0.000937	0.00496	CcSEcCtD
Chlorzoxazone—Somnolence—Gemfibrozil—coronary artery disease	0.000936	0.00495	CcSEcCtD
Chlorzoxazone—Dyspepsia—Gemfibrozil—coronary artery disease	0.000927	0.00491	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Fenofibrate—coronary artery disease	0.000914	0.00484	CcSEcCtD
Chlorzoxazone—Drowsiness—Furosemide—coronary artery disease	0.000911	0.00482	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.000909	0.00481	CcSEcCtD
Chlorzoxazone—Dyspepsia—Ticagrelor—coronary artery disease	0.000906	0.00479	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Acetylsalicylic acid—coronary artery disease	0.0009	0.00476	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Lovastatin—coronary artery disease	0.000892	0.00472	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.000888	0.0047	CcSEcCtD
Chlorzoxazone—Malaise—Fenofibrate—coronary artery disease	0.000888	0.0047	CcSEcCtD
Chlorzoxazone—Angioedema—Clopidogrel—coronary artery disease	0.000885	0.00468	CcSEcCtD
Chlorzoxazone—Angioedema—Lovastatin—coronary artery disease	0.000879	0.00465	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Ezetimibe—coronary artery disease	0.000875	0.00463	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Gemfibrozil—coronary artery disease	0.000868	0.00459	CcSEcCtD
Chlorzoxazone—Malaise—Lovastatin—coronary artery disease	0.000867	0.00459	CcSEcCtD
Chlorzoxazone—Angioedema—Ezetimibe—coronary artery disease	0.000862	0.00456	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Eplerenone—coronary artery disease	0.000857	0.00453	CcSEcCtD
Chlorzoxazone—Malaise—Ezetimibe—coronary artery disease	0.000851	0.0045	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ticagrelor—coronary artery disease	0.000848	0.00449	CcSEcCtD
Chlorzoxazone—Angioedema—Eplerenone—coronary artery disease	0.000844	0.00446	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Simvastatin—coronary artery disease	0.000835	0.00442	CcSEcCtD
Chlorzoxazone—Malaise—Eplerenone—coronary artery disease	0.000833	0.00441	CcSEcCtD
Chlorzoxazone—Discomfort—Fenofibrate—coronary artery disease	0.000828	0.00438	CcSEcCtD
Chlorzoxazone—Angioedema—Simvastatin—coronary artery disease	0.000822	0.00435	CcSEcCtD
Chlorzoxazone—Dizziness—Penbutolol—coronary artery disease	0.000816	0.00432	CcSEcCtD
Chlorzoxazone—Dyspepsia—Rosuvastatin—coronary artery disease	0.000815	0.00431	CcSEcCtD
Chlorzoxazone—Malaise—Simvastatin—coronary artery disease	0.000811	0.00429	CcSEcCtD
Chlorzoxazone—Discomfort—Lovastatin—coronary artery disease	0.000809	0.00428	CcSEcCtD
Chlorzoxazone—Somnolence—Acetylsalicylic acid—coronary artery disease	0.0008	0.00423	CcSEcCtD
Chlorzoxazone—Discomfort—Ezetimibe—coronary artery disease	0.000793	0.0042	CcSEcCtD
Chlorzoxazone—Dyspepsia—Acetylsalicylic acid—coronary artery disease	0.000792	0.00419	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Clopidogrel—coronary artery disease	0.00079	0.00418	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Lovastatin—coronary artery disease	0.000785	0.00415	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Olmesartan—coronary artery disease	0.000784	0.00415	CcSEcCtD
Chlorzoxazone—Discomfort—Eplerenone—coronary artery disease	0.000777	0.00411	CcSEcCtD
Chlorzoxazone—Angioedema—Valsartan—coronary artery disease	0.000776	0.00411	CcSEcCtD
Chlorzoxazone—Angioedema—Olmesartan—coronary artery disease	0.000772	0.00409	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Ezetimibe—coronary artery disease	0.00077	0.00407	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Rosuvastatin—coronary artery disease	0.000763	0.00404	CcSEcCtD
Chlorzoxazone—Malaise—Olmesartan—coronary artery disease	0.000762	0.00403	CcSEcCtD
Chlorzoxazone—Discomfort—Simvastatin—coronary artery disease	0.000757	0.004	CcSEcCtD
Chlorzoxazone—Angioedema—Niacin—coronary artery disease	0.000755	0.00399	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Pravastatin—coronary artery disease	0.000755	0.00399	CcSEcCtD
Chlorzoxazone—Angioedema—Pravastatin—coronary artery disease	0.000743	0.00393	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Acetylsalicylic acid—coronary artery disease	0.000741	0.00392	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Simvastatin—coronary artery disease	0.000734	0.00388	CcSEcCtD
Chlorzoxazone—Malaise—Pravastatin—coronary artery disease	0.000733	0.00388	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Trandolapril—coronary artery disease	0.000733	0.00388	CcSEcCtD
Chlorzoxazone—KCNMA1—heart—coronary artery disease	0.000728	0.0656	CbGeAlD
Chlorzoxazone—Angioedema—Trandolapril—coronary artery disease	0.000722	0.00382	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Telmisartan—coronary artery disease	0.00072	0.00381	CcSEcCtD
Chlorzoxazone—Angioedema—Enalapril—coronary artery disease	0.000719	0.0038	CcSEcCtD
Chlorzoxazone—Somnolence—Fenofibrate—coronary artery disease	0.000715	0.00378	CcSEcCtD
Chlorzoxazone—Malaise—Trandolapril—coronary artery disease	0.000712	0.00377	CcSEcCtD
Chlorzoxazone—Discomfort—Olmesartan—coronary artery disease	0.000711	0.00376	CcSEcCtD
Chlorzoxazone—Angioedema—Telmisartan—coronary artery disease	0.000709	0.00375	CcSEcCtD
Chlorzoxazone—Dyspepsia—Fenofibrate—coronary artery disease	0.000708	0.00374	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Captopril—coronary artery disease	0.0007	0.0037	CcSEcCtD
Chlorzoxazone—Malaise—Telmisartan—coronary artery disease	0.0007	0.0037	CcSEcCtD
Chlorzoxazone—Dizziness—Gemfibrozil—coronary artery disease	0.000696	0.00369	CcSEcCtD
Chlorzoxazone—Dyspepsia—Clopidogrel—coronary artery disease	0.000695	0.00368	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000694	0.00367	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Valsartan—coronary artery disease	0.000693	0.00367	CcSEcCtD
Chlorzoxazone—Dyspepsia—Lovastatin—coronary artery disease	0.000691	0.00366	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Olmesartan—coronary artery disease	0.00069	0.00365	CcSEcCtD
Chlorzoxazone—Angioedema—Captopril—coronary artery disease	0.000689	0.00365	CcSEcCtD
Chlorzoxazone—KCNMA1—cardiovascular system—coronary artery disease	0.000687	0.0619	CbGeAlD
Chlorzoxazone—Discomfort—Pravastatin—coronary artery disease	0.000684	0.00362	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000682	0.00361	CcSEcCtD
Chlorzoxazone—Dizziness—Ticagrelor—coronary artery disease	0.00068	0.0036	CcSEcCtD
Chlorzoxazone—Malaise—Captopril—coronary artery disease	0.00068	0.0036	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Perindopril—coronary artery disease	0.00068	0.0036	CcSEcCtD
Chlorzoxazone—Dyspepsia—Ezetimibe—coronary artery disease	0.000678	0.00359	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Niacin—coronary artery disease	0.000674	0.00357	CcSEcCtD
Chlorzoxazone—Angioedema—Perindopril—coronary artery disease	0.000669	0.00354	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000665	0.00352	CcSEcCtD
Chlorzoxazone—Discomfort—Trandolapril—coronary artery disease	0.000664	0.00351	CcSEcCtD
Chlorzoxazone—Rash—Gemfibrozil—coronary artery disease	0.000664	0.00351	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Pravastatin—coronary artery disease	0.000664	0.00351	CcSEcCtD
Chlorzoxazone—Dermatitis—Gemfibrozil—coronary artery disease	0.000663	0.00351	CcSEcCtD
Chlorzoxazone—Dyspepsia—Eplerenone—coronary artery disease	0.000663	0.00351	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Fenofibrate—coronary artery disease	0.000662	0.0035	CcSEcCtD
Chlorzoxazone—Discomfort—Enalapril—coronary artery disease	0.000662	0.0035	CcSEcCtD
Chlorzoxazone—Malaise—Perindopril—coronary artery disease	0.000661	0.00349	CcSEcCtD
Chlorzoxazone—Discomfort—Telmisartan—coronary artery disease	0.000653	0.00345	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Clopidogrel—coronary artery disease	0.000651	0.00345	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.00065	0.00344	CcSEcCtD
Chlorzoxazone—Rash—Ticagrelor—coronary artery disease	0.000649	0.00343	CcSEcCtD
Chlorzoxazone—Dermatitis—Ticagrelor—coronary artery disease	0.000648	0.00343	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Lovastatin—coronary artery disease	0.000647	0.00342	CcSEcCtD
Chlorzoxazone—Dyspepsia—Simvastatin—coronary artery disease	0.000646	0.00342	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Enalapril—coronary artery disease	0.000642	0.0034	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Losartan—coronary artery disease	0.000637	0.00337	CcSEcCtD
Chlorzoxazone—Discomfort—Captopril—coronary artery disease	0.000635	0.00336	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ezetimibe—coronary artery disease	0.000634	0.00336	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000634	0.00335	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Telmisartan—coronary artery disease	0.000633	0.00335	CcSEcCtD
Chlorzoxazone—Angioedema—Losartan—coronary artery disease	0.000628	0.00332	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Eplerenone—coronary artery disease	0.000621	0.00329	CcSEcCtD
Chlorzoxazone—Malaise—Losartan—coronary artery disease	0.00062	0.00328	CcSEcCtD
Chlorzoxazone—Somnolence—Valsartan—coronary artery disease	0.000616	0.00326	CcSEcCtD
Chlorzoxazone—Discomfort—Perindopril—coronary artery disease	0.000616	0.00326	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Captopril—coronary artery disease	0.000616	0.00326	CcSEcCtD
Chlorzoxazone—Dizziness—Rosuvastatin—coronary artery disease	0.000612	0.00324	CcSEcCtD
Chlorzoxazone—Dyspepsia—Valsartan—coronary artery disease	0.00061	0.00323	CcSEcCtD
Chlorzoxazone—Dyspepsia—Olmesartan—coronary artery disease	0.000607	0.00321	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Simvastatin—coronary artery disease	0.000605	0.0032	CcSEcCtD
Chlorzoxazone—Somnolence—Niacin—coronary artery disease	0.000599	0.00317	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000599	0.00317	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Perindopril—coronary artery disease	0.000598	0.00316	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000596	0.00315	CcSEcCtD
Chlorzoxazone—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000595	0.00315	CcSEcCtD
Chlorzoxazone—Dyspepsia—Niacin—coronary artery disease	0.000593	0.00314	CcSEcCtD
Chlorzoxazone—Dyspepsia—Pravastatin—coronary artery disease	0.000584	0.00309	CcSEcCtD
Chlorzoxazone—Rash—Rosuvastatin—coronary artery disease	0.000584	0.00309	CcSEcCtD
Chlorzoxazone—Dermatitis—Rosuvastatin—coronary artery disease	0.000583	0.00309	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Niacin—coronary artery disease	0.000582	0.00308	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Furosemide—coronary artery disease	0.000581	0.00307	CcSEcCtD
Chlorzoxazone—Discomfort—Losartan—coronary artery disease	0.000578	0.00306	CcSEcCtD
Chlorzoxazone—Somnolence—Trandolapril—coronary artery disease	0.000573	0.00303	CcSEcCtD
Chlorzoxazone—Somnolence—Enalapril—coronary artery disease	0.000571	0.00302	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Olmesartan—coronary artery disease	0.000569	0.00301	CcSEcCtD
Chlorzoxazone—Dyspepsia—Trandolapril—coronary artery disease	0.000567	0.003	CcSEcCtD
Chlorzoxazone—Rash—Acetylsalicylic acid—coronary artery disease	0.000567	0.003	CcSEcCtD
Chlorzoxazone—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000567	0.003	CcSEcCtD
Chlorzoxazone—Dyspepsia—Enalapril—coronary artery disease	0.000565	0.00299	CcSEcCtD
Chlorzoxazone—Somnolence—Telmisartan—coronary artery disease	0.000563	0.00298	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Losartan—coronary artery disease	0.000561	0.00297	CcSEcCtD
Chlorzoxazone—Dyspepsia—Telmisartan—coronary artery disease	0.000557	0.00295	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000556	0.00294	CcSEcCtD
Chlorzoxazone—Somnolence—Captopril—coronary artery disease	0.000547	0.0029	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Pravastatin—coronary artery disease	0.000547	0.00289	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000547	0.00289	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Ramipril—coronary artery disease	0.000547	0.00289	CcSEcCtD
Chlorzoxazone—Dyspepsia—Captopril—coronary artery disease	0.000542	0.00287	CcSEcCtD
Chlorzoxazone—Angioedema—Ramipril—coronary artery disease	0.000538	0.00285	CcSEcCtD
Chlorzoxazone—Dizziness—Fenofibrate—coronary artery disease	0.000532	0.00281	CcSEcCtD
Chlorzoxazone—Somnolence—Perindopril—coronary artery disease	0.000531	0.00281	CcSEcCtD
Chlorzoxazone—Malaise—Ramipril—coronary artery disease	0.000531	0.00281	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Trandolapril—coronary artery disease	0.000531	0.00281	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Enalapril—coronary artery disease	0.000529	0.0028	CcSEcCtD
Chlorzoxazone—Angioedema—Timolol—coronary artery disease	0.000526	0.00278	CcSEcCtD
Chlorzoxazone—Dyspepsia—Perindopril—coronary artery disease	0.000526	0.00278	CcSEcCtD
Chlorzoxazone—Dizziness—Clopidogrel—coronary artery disease	0.000522	0.00276	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Telmisartan—coronary artery disease	0.000522	0.00276	CcSEcCtD
Chlorzoxazone—Dizziness—Lovastatin—coronary artery disease	0.000519	0.00275	CcSEcCtD
Chlorzoxazone—Somnolence—Furosemide—coronary artery disease	0.000517	0.00273	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000516	0.00273	CcSEcCtD
Chlorzoxazone—Dizziness—Ezetimibe—coronary artery disease	0.000509	0.00269	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Captopril—coronary artery disease	0.000507	0.00268	CcSEcCtD
Chlorzoxazone—Rash—Fenofibrate—coronary artery disease	0.000507	0.00268	CcSEcCtD
Chlorzoxazone—Dermatitis—Fenofibrate—coronary artery disease	0.000506	0.00268	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000502	0.00265	CcSEcCtD
Chlorzoxazone—Somnolence—Losartan—coronary artery disease	0.000498	0.00264	CcSEcCtD
Chlorzoxazone—Dizziness—Eplerenone—coronary artery disease	0.000498	0.00264	CcSEcCtD
Chlorzoxazone—Rash—Clopidogrel—coronary artery disease	0.000498	0.00264	CcSEcCtD
Chlorzoxazone—Dermatitis—Clopidogrel—coronary artery disease	0.000498	0.00263	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Lisinopril—coronary artery disease	0.000496	0.00262	CcSEcCtD
Chlorzoxazone—Discomfort—Ramipril—coronary artery disease	0.000496	0.00262	CcSEcCtD
Chlorzoxazone—Rash—Lovastatin—coronary artery disease	0.000495	0.00262	CcSEcCtD
Chlorzoxazone—Dermatitis—Lovastatin—coronary artery disease	0.000494	0.00262	CcSEcCtD
Chlorzoxazone—Dyspepsia—Losartan—coronary artery disease	0.000494	0.00261	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Perindopril—coronary artery disease	0.000493	0.00261	CcSEcCtD
Chlorzoxazone—Angioedema—Lisinopril—coronary artery disease	0.000488	0.00258	CcSEcCtD
Chlorzoxazone—Dizziness—Simvastatin—coronary artery disease	0.000485	0.00257	CcSEcCtD
Chlorzoxazone—Rash—Ezetimibe—coronary artery disease	0.000485	0.00257	CcSEcCtD
Chlorzoxazone—Dermatitis—Ezetimibe—coronary artery disease	0.000485	0.00257	CcSEcCtD
Chlorzoxazone—Discomfort—Timolol—coronary artery disease	0.000484	0.00256	CcSEcCtD
Chlorzoxazone—Malaise—Lisinopril—coronary artery disease	0.000482	0.00255	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Ramipril—coronary artery disease	0.000481	0.00254	CcSEcCtD
Chlorzoxazone—CYP1A1—cardiac ventricle—coronary artery disease	0.00048	0.0433	CbGeAlD
Chlorzoxazone—Feeling abnormal—Furosemide—coronary artery disease	0.000479	0.00253	CcSEcCtD
Chlorzoxazone—Rash—Eplerenone—coronary artery disease	0.000475	0.00251	CcSEcCtD
Chlorzoxazone—Dermatitis—Eplerenone—coronary artery disease	0.000475	0.00251	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Timolol—coronary artery disease	0.00047	0.00249	CcSEcCtD
Chlorzoxazone—Rash—Simvastatin—coronary artery disease	0.000463	0.00245	CcSEcCtD
Chlorzoxazone—Dermatitis—Simvastatin—coronary artery disease	0.000462	0.00245	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Losartan—coronary artery disease	0.000462	0.00244	CcSEcCtD
Chlorzoxazone—Dizziness—Valsartan—coronary artery disease	0.000458	0.00243	CcSEcCtD
Chlorzoxazone—Dizziness—Olmesartan—coronary artery disease	0.000456	0.00241	CcSEcCtD
Chlorzoxazone—Discomfort—Lisinopril—coronary artery disease	0.000449	0.00238	CcSEcCtD
Chlorzoxazone—Dizziness—Niacin—coronary artery disease	0.000446	0.00236	CcSEcCtD
Chlorzoxazone—Dizziness—Pravastatin—coronary artery disease	0.000439	0.00232	CcSEcCtD
Chlorzoxazone—Rash—Valsartan—coronary artery disease	0.000437	0.00231	CcSEcCtD
Chlorzoxazone—Dermatitis—Valsartan—coronary artery disease	0.000437	0.00231	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Lisinopril—coronary artery disease	0.000436	0.00231	CcSEcCtD
Chlorzoxazone—Rash—Olmesartan—coronary artery disease	0.000435	0.0023	CcSEcCtD
Chlorzoxazone—Dermatitis—Olmesartan—coronary artery disease	0.000435	0.0023	CcSEcCtD
Chlorzoxazone—Somnolence—Ramipril—coronary artery disease	0.000427	0.00226	CcSEcCtD
Chlorzoxazone—Dizziness—Trandolapril—coronary artery disease	0.000426	0.00226	CcSEcCtD
Chlorzoxazone—Rash—Niacin—coronary artery disease	0.000425	0.00225	CcSEcCtD
Chlorzoxazone—Dermatitis—Niacin—coronary artery disease	0.000425	0.00225	CcSEcCtD
Chlorzoxazone—Dizziness—Enalapril—coronary artery disease	0.000424	0.00225	CcSEcCtD
Chlorzoxazone—Dyspepsia—Ramipril—coronary artery disease	0.000423	0.00224	CcSEcCtD
Chlorzoxazone—Dizziness—Telmisartan—coronary artery disease	0.000419	0.00222	CcSEcCtD
Chlorzoxazone—Rash—Pravastatin—coronary artery disease	0.000418	0.00221	CcSEcCtD
Chlorzoxazone—Dermatitis—Pravastatin—coronary artery disease	0.000418	0.00221	CcSEcCtD
Chlorzoxazone—Somnolence—Timolol—coronary artery disease	0.000418	0.00221	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000415	0.0022	CcSEcCtD
Chlorzoxazone—Dyspepsia—Timolol—coronary artery disease	0.000414	0.00219	CcSEcCtD
Chlorzoxazone—Dizziness—Captopril—coronary artery disease	0.000407	0.00215	CcSEcCtD
Chlorzoxazone—Rash—Trandolapril—coronary artery disease	0.000406	0.00215	CcSEcCtD
Chlorzoxazone—Dermatitis—Trandolapril—coronary artery disease	0.000406	0.00215	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Timolol—coronary artery disease	0.000406	0.00215	CcSEcCtD
Chlorzoxazone—Rash—Enalapril—coronary artery disease	0.000405	0.00214	CcSEcCtD
Chlorzoxazone—Dermatitis—Enalapril—coronary artery disease	0.000404	0.00214	CcSEcCtD
Chlorzoxazone—Rash—Telmisartan—coronary artery disease	0.000399	0.00211	CcSEcCtD
Chlorzoxazone—Dermatitis—Telmisartan—coronary artery disease	0.000399	0.00211	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ramipril—coronary artery disease	0.000396	0.0021	CcSEcCtD
Chlorzoxazone—Dizziness—Perindopril—coronary artery disease	0.000395	0.00209	CcSEcCtD
Chlorzoxazone—Rash—Captopril—coronary artery disease	0.000388	0.00205	CcSEcCtD
Chlorzoxazone—Dermatitis—Captopril—coronary artery disease	0.000388	0.00205	CcSEcCtD
Chlorzoxazone—Somnolence—Lisinopril—coronary artery disease	0.000388	0.00205	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Timolol—coronary artery disease	0.000387	0.00205	CcSEcCtD
Chlorzoxazone—Dizziness—Furosemide—coronary artery disease	0.000384	0.00203	CcSEcCtD
Chlorzoxazone—Dyspepsia—Lisinopril—coronary artery disease	0.000384	0.00203	CcSEcCtD
Chlorzoxazone—Rash—Perindopril—coronary artery disease	0.000377	0.00199	CcSEcCtD
Chlorzoxazone—Dermatitis—Perindopril—coronary artery disease	0.000377	0.00199	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000376	0.00199	CcSEcCtD
Chlorzoxazone—Dizziness—Losartan—coronary artery disease	0.000371	0.00196	CcSEcCtD
Chlorzoxazone—Rash—Furosemide—coronary artery disease	0.000366	0.00194	CcSEcCtD
Chlorzoxazone—Dermatitis—Furosemide—coronary artery disease	0.000366	0.00194	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Lisinopril—coronary artery disease	0.000359	0.0019	CcSEcCtD
Chlorzoxazone—Rash—Losartan—coronary artery disease	0.000354	0.00187	CcSEcCtD
Chlorzoxazone—Dermatitis—Losartan—coronary artery disease	0.000353	0.00187	CcSEcCtD
Chlorzoxazone—Dizziness—Ramipril—coronary artery disease	0.000318	0.00168	CcSEcCtD
Chlorzoxazone—CYP1A1—heart—coronary artery disease	0.000315	0.0284	CbGeAlD
Chlorzoxazone—Dizziness—Timolol—coronary artery disease	0.000311	0.00164	CcSEcCtD
Chlorzoxazone—Rash—Ramipril—coronary artery disease	0.000303	0.0016	CcSEcCtD
Chlorzoxazone—Dermatitis—Ramipril—coronary artery disease	0.000303	0.0016	CcSEcCtD
Chlorzoxazone—Rash—Timolol—coronary artery disease	0.000296	0.00157	CcSEcCtD
Chlorzoxazone—Dermatitis—Timolol—coronary artery disease	0.000296	0.00157	CcSEcCtD
Chlorzoxazone—Dizziness—Lisinopril—coronary artery disease	0.000288	0.00153	CcSEcCtD
Chlorzoxazone—Rash—Lisinopril—coronary artery disease	0.000275	0.00145	CcSEcCtD
Chlorzoxazone—Dermatitis—Lisinopril—coronary artery disease	0.000275	0.00145	CcSEcCtD
Chlorzoxazone—CYP2E1—cardiovascular system—coronary artery disease	0.000271	0.0244	CbGeAlD
Chlorzoxazone—CYP1A1—cardiac atrium—coronary artery disease	0.00027	0.0243	CbGeAlD
Chlorzoxazone—CYP1A2—blood—coronary artery disease	0.000238	0.0215	CbGeAlD
Chlorzoxazone—CYP1A1—blood—coronary artery disease	0.000235	0.0212	CbGeAlD
Chlorzoxazone—CYP2E1—blood—coronary artery disease	0.000215	0.0193	CbGeAlD
Chlorzoxazone—CYP3A4—blood—coronary artery disease	0.000173	0.0156	CbGeAlD
Chlorzoxazone—CYP2D6—blood—coronary artery disease	0.00017	0.0153	CbGeAlD
Chlorzoxazone—CYP1A2—Metabolism—APOA2—coronary artery disease	1.26e-05	7.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTM1—coronary artery disease	1.25e-05	7.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCG5—coronary artery disease	1.25e-05	7.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX4—coronary artery disease	1.25e-05	7.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SULT1A1—coronary artery disease	1.25e-05	7.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HK1—coronary artery disease	1.25e-05	7.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.25e-05	7.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ABCA1—coronary artery disease	1.24e-05	7.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—VCAN—coronary artery disease	1.24e-05	7.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HADHA—coronary artery disease	1.23e-05	7.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—LPL—coronary artery disease	1.23e-05	7.71e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALDOA—coronary artery disease	1.23e-05	7.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HK2—coronary artery disease	1.23e-05	7.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.23e-05	7.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTA1—coronary artery disease	1.22e-05	7.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LPA—coronary artery disease	1.21e-05	7.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PLCB1—coronary artery disease	1.21e-05	7.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPX1—coronary artery disease	1.2e-05	7.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GGT1—coronary artery disease	1.2e-05	7.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GOT1—coronary artery disease	1.2e-05	7.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—DCN—coronary artery disease	1.19e-05	7.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.18e-05	7.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.18e-05	7.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CD36—coronary artery disease	1.17e-05	7.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ABCA1—coronary artery disease	1.17e-05	7.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLCB3—coronary artery disease	1.17e-05	7.32e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALDH2—coronary artery disease	1.16e-05	7.27e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOA5—coronary artery disease	1.16e-05	7.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.16e-05	7.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LCAT—coronary artery disease	1.16e-05	7.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPP2CA—coronary artery disease	1.16e-05	7.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—P4HB—coronary artery disease	1.13e-05	7.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOA4—coronary artery disease	1.13e-05	7.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GGT1—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GOT1—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LIPC—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HBA1—coronary artery disease	1.13e-05	7.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOC3—coronary artery disease	1.12e-05	7.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.12e-05	7.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LDLR—coronary artery disease	1.12e-05	7e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	1.11e-05	6.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—coronary artery disease	1.11e-05	6.94e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.1e-05	6.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.1e-05	6.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.1e-05	6.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.09e-05	6.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCLM—coronary artery disease	1.09e-05	6.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CETP—coronary artery disease	1.09e-05	6.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GCLC—coronary artery disease	1.09e-05	6.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.09e-05	6.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SDC1—coronary artery disease	1.08e-05	6.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—coronary artery disease	1.08e-05	6.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARGC1A—coronary artery disease	1.07e-05	6.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HMOX1—coronary artery disease	1.06e-05	6.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.06e-05	6.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.06e-05	6.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AGT—coronary artery disease	1.05e-05	6.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAT—coronary artery disease	1.05e-05	6.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—VCAN—coronary artery disease	1.05e-05	6.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.04e-05	6.54e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.04e-05	6.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOE—coronary artery disease	1.03e-05	6.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.03e-05	6.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HADH—coronary artery disease	1.03e-05	6.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOA1—coronary artery disease	1.02e-05	6.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.02e-05	6.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.02e-05	6.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOB—coronary artery disease	1.02e-05	6.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—coronary artery disease	1.02e-05	6.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—DCN—coronary artery disease	1.01e-05	6.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	1.01e-05	6.31e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HMOX1—coronary artery disease	1e-05	6.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CTGF—coronary artery disease	9.96e-06	6.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—coronary artery disease	9.91e-06	6.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAT—coronary artery disease	9.89e-06	6.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMGCR—coronary artery disease	9.87e-06	6.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GOT2—coronary artery disease	9.87e-06	6.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALDH2—coronary artery disease	9.83e-06	6.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.76e-06	6.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX2—coronary artery disease	9.76e-06	6.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOA2—coronary artery disease	9.76e-06	6.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—LPL—coronary artery disease	9.73e-06	6.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HK1—coronary artery disease	9.64e-06	6.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX4—coronary artery disease	9.64e-06	6.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	9.64e-06	6.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCG5—coronary artery disease	9.64e-06	6.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOB—coronary artery disease	9.61e-06	6.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.59e-06	6.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2C19—coronary artery disease	9.58e-06	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HBA1—coronary artery disease	9.58e-06	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	9.58e-06	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LIPC—coronary artery disease	9.58e-06	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HADHA—coronary artery disease	9.53e-06	5.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOC3—coronary artery disease	9.52e-06	5.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPX1—coronary artery disease	9.49e-06	5.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LDLR—coronary artery disease	9.47e-06	5.93e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.46e-06	5.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA1—coronary artery disease	9.42e-06	5.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTT1—coronary artery disease	9.35e-06	5.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC9A1—coronary artery disease	9.35e-06	5.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—coronary artery disease	9.34e-06	5.85e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LPA—coronary artery disease	9.31e-06	5.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCLC—coronary artery disease	9.25e-06	5.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CETP—coronary artery disease	9.25e-06	5.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CD36—coronary artery disease	9.24e-06	5.79e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—LPL—coronary artery disease	9.17e-06	5.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SDC1—coronary artery disease	9.14e-06	5.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPP2CA—coronary artery disease	9.13e-06	5.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PLCB1—coronary artery disease	9.08e-06	5.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLCB3—coronary artery disease	9.02e-06	5.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARG—coronary artery disease	8.99e-06	5.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPX1—coronary artery disease	8.95e-06	5.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOA5—coronary artery disease	8.93e-06	5.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—POMC—coronary artery disease	8.86e-06	5.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ABCA1—coronary artery disease	8.8e-06	5.51e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—coronary artery disease	8.76e-06	5.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—P4HB—coronary artery disease	8.75e-06	5.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CD36—coronary artery disease	8.71e-06	5.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PSMB5—coronary artery disease	8.64e-06	5.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PSMA6—coronary artery disease	8.64e-06	5.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.62e-06	5.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPP2CA—coronary artery disease	8.61e-06	5.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	8.59e-06	5.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GGT1—coronary artery disease	8.52e-06	5.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GOT1—coronary artery disease	8.52e-06	5.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CTGF—coronary artery disease	8.44e-06	5.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMGCR—coronary artery disease	8.36e-06	5.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GOT2—coronary artery disease	8.36e-06	5.24e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AGT—coronary artery disease	8.32e-06	5.21e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—coronary artery disease	8.26e-06	5.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOE—coronary artery disease	8.15e-06	5.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—VCAN—coronary artery disease	8.1e-06	5.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ALB—coronary artery disease	8.08e-06	5.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOA1—coronary artery disease	8.06e-06	5.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALDOA—coronary artery disease	8.04e-06	5.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AGT—coronary artery disease	7.85e-06	4.92e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—DCN—coronary artery disease	7.8e-06	4.89e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NOS3—coronary artery disease	7.73e-06	4.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLCB1—coronary artery disease	7.69e-06	4.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOE—coronary artery disease	7.69e-06	4.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—coronary artery disease	7.65e-06	4.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOA1—coronary artery disease	7.6e-06	4.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.59e-06	4.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	7.58e-06	4.75e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMOX1—coronary artery disease	7.55e-06	4.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.54e-06	4.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCA1—coronary artery disease	7.45e-06	4.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAT—coronary artery disease	7.45e-06	4.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.4e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.4e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LIPC—coronary artery disease	7.4e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HBA1—coronary artery disease	7.4e-06	4.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOC3—coronary artery disease	7.35e-06	4.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LDLR—coronary artery disease	7.31e-06	4.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.28e-06	4.56e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOB—coronary artery disease	7.23e-06	4.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.22e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.22e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GOT1—coronary artery disease	7.22e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GGT1—coronary artery disease	7.22e-06	4.52e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCLC—coronary artery disease	7.14e-06	4.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CETP—coronary artery disease	7.14e-06	4.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARG—coronary artery disease	7.1e-06	4.45e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTGS2—coronary artery disease	7.07e-06	4.43e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SDC1—coronary artery disease	7.06e-06	4.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—coronary artery disease	7.03e-06	4.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—POMC—coronary artery disease	7.01e-06	4.39e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—LPL—coronary artery disease	6.9e-06	4.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPX1—coronary artery disease	6.74e-06	4.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARG—coronary artery disease	6.7e-06	4.2e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.67e-06	4.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.67e-06	4.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—POMC—coronary artery disease	6.6e-06	4.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CD36—coronary artery disease	6.56e-06	4.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CTGF—coronary artery disease	6.51e-06	4.08e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—coronary artery disease	6.48e-06	4.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.48e-06	4.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.45e-06	4.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GOT2—coronary artery disease	6.45e-06	4.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	6.42e-06	4.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMOX1—coronary artery disease	6.39e-06	4.01e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ALB—coronary artery disease	6.39e-06	4e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAT—coronary artery disease	6.31e-06	3.95e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—coronary artery disease	6.22e-06	3.89e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOB—coronary artery disease	6.12e-06	3.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NOS3—coronary artery disease	6.11e-06	3.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ALB—coronary artery disease	6.02e-06	3.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—coronary artery disease	5.96e-06	3.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.93e-06	3.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AGT—coronary artery disease	5.91e-06	3.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—LPL—coronary artery disease	5.85e-06	3.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOE—coronary artery disease	5.79e-06	3.63e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NOS3—coronary artery disease	5.76e-06	3.61e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.75e-06	3.6e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOA1—coronary artery disease	5.72e-06	3.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX1—coronary artery disease	5.71e-06	3.57e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTGS2—coronary artery disease	5.59e-06	3.5e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GGT1—coronary artery disease	5.57e-06	3.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GOT1—coronary artery disease	5.57e-06	3.49e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CD36—coronary artery disease	5.56e-06	3.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.49e-06	3.44e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTGS2—coronary artery disease	5.27e-06	3.3e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.27e-06	3.3e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARG—coronary artery disease	5.04e-06	3.16e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—coronary artery disease	5e-06	3.14e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AGT—coronary artery disease	5e-06	3.13e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—POMC—coronary artery disease	4.97e-06	3.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.96e-06	3.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.93e-06	3.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOE—coronary artery disease	4.9e-06	3.07e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAT—coronary artery disease	4.87e-06	3.05e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOA1—coronary artery disease	4.85e-06	3.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOB—coronary artery disease	4.73e-06	2.96e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.64e-06	2.91e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.6e-06	2.88e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ALB—coronary artery disease	4.53e-06	2.84e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—LPL—coronary artery disease	4.51e-06	2.83e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX1—coronary artery disease	4.4e-06	2.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CA—coronary artery disease	4.35e-06	2.73e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NOS3—coronary artery disease	4.34e-06	2.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CD36—coronary artery disease	4.29e-06	2.69e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARG—coronary artery disease	4.27e-06	2.68e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.23e-06	2.65e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—POMC—coronary artery disease	4.21e-06	2.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.06e-06	2.55e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.96e-06	2.48e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AGT—coronary artery disease	3.86e-06	2.42e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ALB—coronary artery disease	3.84e-06	2.41e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOE—coronary artery disease	3.78e-06	2.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOA1—coronary artery disease	3.74e-06	2.34e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NOS3—coronary artery disease	3.67e-06	2.3e-05	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—coronary artery disease	3.55e-06	2.23e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CA—coronary artery disease	3.44e-06	2.15e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.36e-06	2.1e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARG—coronary artery disease	3.3e-06	2.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—POMC—coronary artery disease	3.25e-06	2.04e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CA—coronary artery disease	3.24e-06	2.03e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ALB—coronary artery disease	2.96e-06	1.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NOS3—coronary artery disease	2.83e-06	1.78e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—coronary artery disease	2.81e-06	1.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—coronary artery disease	2.65e-06	1.66e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.59e-06	1.62e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.44e-06	1.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.07e-06	1.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—coronary artery disease	1.99e-06	1.25e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—coronary artery disease	1.69e-06	1.06e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.59e-06	9.99e-06	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—coronary artery disease	1.3e-06	8.16e-06	CbGpPWpGaD
